Delaware Select Growth Fund*

Key features

  • Differentiated approach to growth investing with an emphasis on intrinsic business value and the cash economics of a business
  • Concentrated, actively managed approach
  • Long-term investment horizon focused on generating attractive risk-adjusted returns
Fund information
Inception date05/16/1994
Dividends paid (if any)Annually
Capital gains paid (if any)November or December
Fund identifiers
NASDAQDVEAX
CUSIP928931104
Investment minimums
Initial investment$1,000
Subsequent investments$100
Systematic withdrawal balance$5,000
Account features
Payroll deductionYes
IRAsYes

On Sept. 25, 2014, Class B shares of the Fund converted to Class A shares.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance quoted.

Total returns may reflect waivers and/or expense reimbursements by the manager and/or distributor for some or all of the periods shown. Performance would have been lower without such waivers and reimbursements.

Average annual total return

as of month-end (12/31/2019)

as of quarter-end (12/31/2019)

YTD1 year3 year5 year10 yearLifetimeInception date
NAV (view definition)27.43%27.43%14.85%8.16%12.51%10.29%05/16/1994
Max offer price20.08%20.08%12.61%6.89%11.85%10.04%
Russell 3000 Growth Index35.85%35.85%19.89%14.23%15.05%n/a
1 year3 year5 year10 yearLifetimeInception date
NAV (view definition)8.07%27.43%14.85%8.16%12.51%10.29%05/16/1994
Max offer price1.86%20.08%12.61%6.89%11.85%10.04%
Russell 3000 Growth Index10.67%35.85%19.89%14.23%15.05%n/a

Returns for less than one year are not annualized.

Class A shares have a maximum up-front sales charge of 5.75% and are subject to an annual distribution fee.

Index performance returns do not reflect any management fees, transaction costs, or expenses. Indices are unmanaged and one cannot invest directly in an index.

Expense ratio
Gross1.24%
Net1.24%
Quarterly total returns @ NAV
Year1st quarter2nd quarter3rd quarter4th quarterAnnual return
201916.31%6.12%-4.46%8.07%27.43%
20181.72%6.01%5.30%-14.32%-2.70%
20175.25%3.97%8.28%3.14%22.20%
2016-6.09%-1.51%9.88%-3.45%-1.88%
20153.48%0.74%-10.53%6.74%-0.44%
2014-1.23%3.45%-3.16%7.93%6.79%
20138.18%0.97%10.59%8.90%31.53%
201217.67%-5.14%4.42%-1.06%15.31%
20119.80%2.19%-11.23%7.86%7.42%
20106.18%-6.23%15.12%10.15%26.25%
20090.49%23.21%15.48%9.78%56.96%
Portfolio characteristics - as of 12/31/2019Russell 3000 Growth Index
Number of holdings681,438
Market cap (median) Source: FactSet$13.5 billion1811944000.000000000
Market cap (weighted average) Source: FactSet$165.7 billion364497573539.380000000
Portfolio turnover (last fiscal year)48%n/a
Beta (relative to Russell 3000 Growth Index) (view definition)1.01n/a
Annualized standard deviation, 3 years (view definition)14.56n/a
Portfolio composition as of 09/30/2019Total may not equal 100% due to rounding.
Domestic equities91.4%
International equities & depositary receipts6.3%
Cash and cash equivalents2.3%
Top 10 holdings as of 12/31/2019

Holdings are as of the date indicated and subject to change.

List may exclude cash, cash equivalents, and exchanged-traded funds (ETFs) that are used for cash management purposes. Please see the Fund’s complete list of holdings for more information.

Holdings based by issuer.

Holding% of portfolio
MICROSOFT CORP9.04%
NEW YORK TIMES COMPANY (THE)7.51%
ACXIOM LLC5.26%
BALL CORP3.51%
Charter Communications Inc.3.28%
Autodesk Inc.3.15%
CHARLES SCHWAB CORP3.07%
Varonis Systems Inc.3.02%
Visa Inc.2.78%
UnitedHealth Group Inc.2.72%
Total % Portfolio in Top 10 holdings43.34%
Sector allocation as of 12/31/2019

List may exclude cash, cash equivalents, and exchanged-traded funds (ETFs) that are used for cash management purposes. Please see the Fund’s complete list of holdings for more information.

SectorFund
Information technology35.5%
Communication services16.7%
Consumer discretionary12.3%
Healthcare11.9%
Financials8.5%
Industrials4.7%
Materials3.5%
Consumer staples2.5%
Real estate1.4%
Energy0.3%
Distribution history - annual distributions (Class A)1,2
Distributions ($ per share)
YearCapital gains3Net investment
income
20192.5850.000
20189.6340.000
20172.2380.000
20165.2120.000
20159.7200.000
20145.7790.090
20131.7770.000
20120.0000.000
20110.0000.000
20100.0000.000
20090.0000.000

1If a Fund makes a distribution from any source other than net income, it is required to provide shareholders with a notice disclosing the source of such distribution (each a "Notice"). The amounts and sources of distributions reported above and in each Notice are only estimates and are not provided for tax reporting purposes. Each Fund will send each shareholder a Form 1099 DIV for the calendar year that will provide definitive information on how to report the Fund's distributions for federal income tax purposes. The information in the table above will not be updated to reflect any subsequent recharacterization of dividends and distributions. Click here to see recent Notices pertaining to the Fund (if any).

2Information on return of capital distributions (if any) is only provided from June 1, 2014 onward.

3Includes both short- and long-term capital gains.

Investment manager

Delaware Management Company (DMC)

Sub-advisor

Jackson Square Partners, LLC


Jeff VanHarte

Jeffrey S. Van Harte, CFA

Chairman, Chief Investment Officer — Jackson Square Partners, LLC

Start date on the Fund: May 2005

Years of industry experience: 39

(View bio)


Chris Bonavico

Christopher J. Bonavico, CFA

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: May 2005

Years of industry experience: 32

(View bio)


Ken Broad

Kenneth F. Broad, CFA

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: May 2005

Years of industry experience: 31

(View bio)


Gregory L. Chory 

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: January 2019

Years of industry experience: 11

(View bio)


Chris Ericksen

Christopher M. Ericksen, CFA

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: July 2007

Years of industry experience: 25

(View bio)


Ian Ferry

Ian D. Ferry 

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: January 2013

Years of industry experience: 15

(View bio)


Patrick Fortier

Patrick G. Fortier, CFA

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: May 2005

Years of industry experience: 24

(View bio)


William Montana

William (Billy) G. Montana 

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: January 2019

Years of industry experience: 10

(View bio)


Daniel J. Prislin

Daniel J. Prislin, CFA

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: May 2005

Years of industry experience: 25

(View bio)


Brian Tolles 

Portfolio Manager, Research Analyst — Jackson Square Partners, LLC

Start date on the Fund: January 2019

Years of industry experience: 5

(View bio)


You may qualify for sales-charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in Delaware Funds® by Macquarie. More information about these and other discounts is available from your financial intermediary, in the Fund's Prospectus under the section entitled "About your account," and in the Fund's statement of additional information (SAI) under the section entitled "Purchasing Shares."

The table below describes the fees and expenses that you may pay if you buy and hold shares of the Fund

Shareholder fees
Maximum sales charge (load) imposed on purchases as a percentage of offering price5.75%
Maximum contingent deferred sales charge (load) as a percentage of original purchase price or redemption price, whichever is lowernone
Annual fund operating expenses
Management fees0.75%
Distribution and service (12b-1) fees0.25%
Other expenses0.24%
Total annual fund operating expenses1.24%
Fee waivers and expense reimbursementsnone
Total annual fund operating expenses after fee waivers and expense reimbursements1.24%

1The Fund's investment manager, Delaware Management Company (Manager), has contractually agreed to waive all or a portion of its investment advisory fees and/or pay/reimburse expenses (excluding any 12b-1 fees, acquired fund fees and expenses, taxes, interest, short sale dividend and interest expenses, brokerage fees, certain insurance costs, and nonroutine expenses or costs, including, but not limited to, those relating to reorganizations, litigation, conducting shareholder meetings, and liquidations) in order to prevent total annual fund operating expenses from exceeding 1.00% of the Fund's average daily net assets from Feb. 28, 2019 through Feb. 28, 2020. These waivers and reimbursements may only be terminated by agreement of the Manager and the Fund.

This commentary is currently not available. Please check back later.

Delaware Select Growth Fund* Quarterly commentary March 31, 2018

Market Review

Despite modestly negative returns for developed market indices, the first quarter of 2018 was a solid one for risk assets as the weaker dollar supported commodities, which in turn benefited emerging market debt and equity. Among economic sectors, technology continued to lead both in the United States and globally, as most sectors were flat to negative for the quarter.

Outperformance of risk assets was also illustrated in US fixed income, as high yield outperformed the Bloomberg Barclays US Aggregate Index despite a rising rate environment and negative returns.

Statistical factors continued recent trends with momentum and growth leading the pack while value trailed. The volatility factor also had weak returns as volatility increased dramatically in the first quarter from historically low levels.

In the US, for the first quarter, the small-mid cap Russell 2500TM Growth gained 2.38% while the large-cap Russell 1000® Growth gained 1.42% and the Russell 3000® Growth gained 1.48%. In the international equity markets, the MSCI ACWI (All Country World Index) Index (net) lost 0.96%.

Within the Fund

While stock exposure largely drove the Fund’s performance, on a sector level, information technology was the largest contributor to performance and financials were the largest detractor.

Wix.com Ltd., a cloud-based web development platform, contributed to the Fund’s performance during the quarter. The company reported a better-than-expected fourth quarter, exceeding expectations on both revenue and collections. The company reported 2017 free cash flow of $70.7 million, up 95% year over year. We believe Wix is well positioned to capture incremental user growth at the expense of its competitors due to its superior search engine optimization and third-party reviews. Longer term, we believe the growth opportunity for the company remains attractive to us, due in part to the fact that there are more than 400 million small and medium businesses, the majority of which have yet to obtain an online presence.

TripAdvisor Inc., a travel website that provides travel advice and planning features, contributed to performance during the quarter. The company reported positive earnings, significantly beating both revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) estimates. The company credits its recent success to the stabilization of its click-based ad auction and lower online acquisition costs. In addition, the company plans to repurchase $250 million worth of shares. Finally, the company added Jay Hoag — co-founder of venture capital firm TCV and Netflix board member — to its board in February, sparking hopes of potential strategic moves, including the possibility of a sale of the company. We believe TripAdvisor is an undervalued asset due to its ability to attract 415 million travelers and based on our view that the company is worth more than recognized at the current valuation.

Bioverativ Inc., a biotech company specializing in the discovery, development, and delivery of therapies for the treatment of hemophilia, was a contributor to the Fund’s performance during the first quarter. Sanofi, a global pharmaceutical company based in France, agreed to buy Bioverativ for $11.6 billion, representing a 64% premium to the previous day’s closing. As a leader in specialty care, Sanofi intends to leverage Bioverativ’s clinical expertise and portfolio in rare blood disorders. Overall, we were pleased with the premium offered.

Element Fleet Management Corp., the largest North American corporate fleet manager, detracted from the Fund’s performance during the quarter. In recent months, the company has been under pressure from activist investors urging the company to explore a sale after disappointing earnings. However, a sale is complicated by how much additional leverage can be added to its fleet leasing business. In addition, to address challenges, management made a series of what we viewed as puzzling decisions that were different than originally planned. We exited the stock given the increased fundamental risk.

Biogen Inc., a biotechnology company focused on neurodegenerative diseases, detracted from performance during the quarter. The company added patients to a phase 3 trial of its primary drug to treat Alzheimer’s, increasing the sample size in order to generate further statistical significance. While the market reacted negatively, we do not believe that trial expansion is necessarily a negative indicator for the drug. The company’s decision to expand the sample size could have been made for various reasons, including potential positive news that patients receiving the drug improved even more than anticipated. We believe that the selloff related to this perceived but unconfirmed trial setback is overblown, and that Biogen’s existing product offerings, attractive and robust pipeline, and progress in the ever-growing field of neurodegenerative and cognitive impairment diseases should continue to drive growth in the long term.

Dentsply Sirona Inc., a dental equipment maker and dental consumables producer, was a detractor from the Fund’s performance during the quarter. The company announced the appointment of Donald Casey as the new CEO, leading investors to speculate about whether or not Casey will follow through with the aggressive cost-savings plan proposed by interim CEO Mark Thierer. The company responded to the speculation, assuring investors that the cost-savings target would stay in place. Furthermore, the board has stated that it is excited about Casey’s experience and hopeful that he can help the company continue its global expansion and improve its distribution. Overall, we believe that the company carries high caliber products that will prevail despite the changing distribution relationships in the industry.

Outlook

After significant positive absolute returns in the equity market over the past several years, some measures of volatility emerged during the first quarter of 2018. The volatility appeared to be both technical and fundamental, leaving investors struggling to accurately predict the pace of global economic recovery and assessing external factors that threaten economic fundamentals, such as central bank actions and fiscal policy debates around the globe. In any given period, including the first quarter, the markets oscillate quickly from sector rotations to stock differentiation and then back again. The result can sometimes be investor focus on equities as an asset class as opposed to a focus on company-specific fundamentals.

President Trump’s unconventional style as a head of state, along with current questions and investigations surrounding his administration, could hamper significant policy change. In the short term, we are mindful of the potential macroeconomic implications of Trump policy shifts (including economic growth and higher corporate and personal incomes from lower tax rates). More recently, President Trump’s comments and public positioning on global trade seems to have created more investor concerns about how a potential global trade war might affect the pace of economic growth. We believe it is too early to determine the long-term magnitude of such outcomes, and we will closely monitor President Trump’s tenure with a keen eye on the execution of significant policy shifts.

Regardless of policy outcomes, we remain consistent in our long-term investment philosophy: We want to own what we view as strong secular-growth companies with solid business models and competitive positions that we believe can grow market share and have the potential to deliver shareholder value in a variety of market environments.

Past performance is not a guarantee of future results.

Index definitions

The S&P 500 Index measures the performance of 500 mostly large-cap stocks weighted by market value, and is often used to represent performance of the US stock market.

The Russell 2000 Index measures the performance of the small-cap segment of the US equity universe.

The MSCI EAFE (Europe, Australasia, Far East) Index is a free float-adjusted market capitalization weighted index designed to measure equity market performance of developed markets, excluding the United States and Canada. Index “net” return approximates the minimum possible dividend reinvestment, after deduction of withholding tax at the highest possible rate.

The MSCI Emerging Markets Index is a free float-adjusted market capitalization index designed to measure equity market performance across emerging market countries worldwide. Index “net” return approximates the minimum possible dividend reinvestment, after deduction of withholding tax at the highest possible rate.

The Russell 2500 Growth Index measures the performance of the small- to mid-cap growth segment of the US equity universe. It includes those Russell 2500 companies with higher price-to-book ratios and higher forecasted growth values.

The Russell 1000 Growth Index measures the performance of the large-cap growth segment of the US equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values.

The Russell 3000 Growth Index measures the performance of the broad growth segment of the US equity universe. It includes those Russell 3000 companies with higher price-to-book ratios and higher forecasted growth values.

Index performance returns do not reflect management fees, transaction costs, or expenses. Indices are unmanaged, and one cannot invest directly in an index.

[467666] 04/18

The views expressed represent the Manager’s assessment of the Fund and market environment as of the date indicated, and should not be considered a recommendation to buy, hold, or sell any security, and should not be relied on as research or investment advice. Information is as of the date indicated and subject to change.

Document must be used in its entirety.

*Effective after the close of business on June 8, 2012, Delaware Select Growth Fund was closed to new investors. Existing shareholders of the Fund; certain retirement plans and IRA transfers and rollovers from these plans; and certain advisory or fee-based programs sponsored by and/or controlled by financial intermediaries where the financial intermediary has entered into an arrangement with the Fund’s Distributor or transfer agent (mutual fund wrap accounts) may continue to purchase shares. Please read the latest prospectus and the summary prospectus for more information concerning this event.

Jackson Square Partners, LLC (JSP), a US registered investment advisor, is the sub-advisor to the Fund. As sub-advisor, JSP is responsible for day-to-day management of the Fund’s assets. Delaware Management Company (DMC), a series of Macquarie Investment Management Business Trust (MIMBT), has ultimate responsibility for all investment advisory services.

All third-party marks cited are the property of their respective owners.

Frank Russell Company is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Frank Russell Company.

Carefully consider the Fund’s investment objectives, risk factors, charges, and expenses before investing. This and other information can be found in the Fund’s prospectus and its summary prospectus, which may be obtained by clicking the prospectus link located in the right-hand sidebar or calling 877 693-3546. Investors should read the prospectus and the summary prospectus carefully before investing.

Investing involves risk, including the possible loss of principal.

Investments in small and/or medium-sized companies typically exhibit greater risk and higher volatility than larger, more established companies.

International investments entail risks not ordinarily associated with US investments including fluctuation in currency values, differences in accounting principles, or economic or political instability in other nations.

Investing in emerging markets can be riskier than investing in established foreign markets due to increased volatility and lower trading volume.

Not FDIC Insured | No Bank Guarantee | May Lose Value

Fund Finder

Daily pricing (as of 01/17/2020)

Class APriceNet change
NAV$34.110.06
Max offer price$36.19n/a

Total net assets (as of 12/31/2019)

$297.6 million all share classes

Morningstar ranking (as of 12/31/2019)

YTD ranking1176 / 1360
1 year1176 / 1360
3 years1005 / 1218
5 years1026 / 1086
10 years607 / 811
Morningstar categoryMorningstar Large Growth Category

(View Morningstar disclosure)

The Morningstar ranking is based on historical total returns.

Lipper ranking (as of 12/31/2019)

YTD ranking443 / 549
1 year443 / 549
3 years395 / 493
5 years382 / 434
10 years206 / 305
Lipper classificationLipper Multi-Cap Growth Funds Average

(View Lipper disclosure)

The Lipper ranking is based on historical total returns.

Benchmark and peer group

Russell 3000® Growth Index (view definition)

Morningstar Large Growth Category (view definition)

Lipper Multi-Cap Growth Funds Average (view definition)

Additional information